BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Ascletis Doses First Patient in Global Phase III Programme for Oral GLP-1 Obesity Drug ASC30

- Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and...

September 01, 2026 | News

The Accidental Gerotherapeutic

METHOD IN BRIEF Outcome evidence in this article is taken from published trial results and approved label language only. No efficacy or outcome claim is s...

August 31, 2026 | Analysis

The Biological Age Business

On coming 4th September at six in the evening Singapore time, a public consultation will close. It opened on 7 August, it is still open as this is publishe...

August 27, 2026 | Analysis

Metabolon Completes Gates Foundation-Funded Metabolomics Studies to Advance Women’s and Infant Health

nnovative sample collection methods developed through Gates Foundation-funded grant enable high-quality metabolomics biomarker discovery in populations fro...

August 27, 2026 | News

ASTRI, Saint Francis University Partner to Advance AI-Enabled Biomaterials and Digital Health

The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU) have signed a Memorandum of Understanding (MoU) ...

August 26, 2026 | News

Pulnovo Medical Enrols First Patients in PULSE-LHD Trial for Pulmonary Hypertension

Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), announced the enrollment of the f...

August 24, 2026 | News

South Korea’s Hanmi Pharm Licenses Obesity Drug HM17321 to Genentech in $2.3B Deal

HM17321, a proprietary UCN2 (urocortin-2) analog, is being developed as a treatment for chronic-weight management and associated conditions, including ob...

August 25, 2026 | News

CureGene Doses First Subject in Australia Phase I Trial of Oral Metabolic Drug CG-0416

CureGene recently announced that the first subject has been dosed in its Phase I clinical trial of CG-0416, a novel oral liver-targeting THR-β agonist...

August 24, 2026 | News

Intuitive to Establish 316,000-Sq-Ft Robotic Surgery Manufacturing Facility in Penang

New 316,000-square-foot facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032 Intuitive (NASDAQ: ISRG), a global t...

August 19, 2026 | News

SingHealth Launches Global Fellowship Network to Develop Future-Ready Healthcare Leaders

SingHealth is working alongside nine leading academic medical centres and health systems worldwide to formalise a structured exchange programme for healt...

August 14, 2026 | News

Thermo Fisher, Michael J. Fox Foundation Expand Parkinson’s Proteomics Resource with 5,500 Samples

Olink™ Explore HT analysis of approximately 5,500 research samples completed, with data now available Key Facts Collaboration: Thermo Fisher...

August 13, 2026 | News

The Sarcopenia Definition Race: The Endpoint Is the Asset

In a category with no approvable indication anywhere in the world, whoever writes the endpoint definition controls who is eligible for a trial, what counts...

August 12, 2026 | Analysis

Haleon, A*STAR Launch Centrum Study on Metabolic Health in Midlife Asian Women

A new clinical study on the multivitamin and mineral supplement Centrum is designed to generate evidence on metabolic health in midlife Asian women - a g...

August 12, 2026 | News

China, Indonesia Cardiologists Complete Southeast Asia’s First Complex CTO Procedure Using uAngio AVIVA

Cardiologists from China and Indonesia have successfully completed Southeast Asia's first complex Chronic Total Occlusion (CTO) procedure guided by United ...

August 11, 2026 | News

Stay Connected